CollPlant Biotechnologies Q4 Adj EPS $(0.35) Misses $(0.07) Estimate, Sales $299.00K Miss $8.56M Estimate
$CLGN
Industrial Specialties
Health Care
CollPlant Biotechnologies (NASDAQ:CLGN) reported quarterly Adj losses of $(0.35) per share which missed the analyst consensus estimate of $(0.07) by 400 percent. This is unchanged from the same period last year. The company reported quarterly sales of $299.00 thousand which missed the analyst consensus estimate of $8.56 million by 96.51 percent. This is a 415.52 percent increase over sales of $58.00 thousand the same period last year.